PROGRESSIVE ABROGATION OF TGF-BETA-1 AND EGF GROWTH-CONTROL IS ASSOCIATED WITH TUMOR PROGRESSION IN RAS-TRANSFECTED HUMAN KERATINOCYTES

被引:65
作者
GAME, SM
HUELSEN, A
PATEL, V
DONNELLY, M
YEUDALL, WA
STONE, A
FUSENIG, NE
PRIME, SS
机构
[1] UNIV BRISTOL,BRISTOL DENT HOSP & SCH,DEPT ORAL MED SURG & PATHOL,BRISTOL BS1 2LY,AVON,ENGLAND
[2] GERMAN CANC RES CTR,DIV CARCINOGENESIS & DIFFERENTIAT,W-6900 HEIDELBERG,GERMANY
关键词
D O I
10.1002/ijc.2910520322
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This study examined the response of human keratinocytes in different stages of transformation to exogenous TGF-beta1 and EGF as well as their receptor and growth-factor expression. Cells of the spontaneously immortalized HaCaT cell line and c-Ha-ras transfected clones (1-6, 1-7, 11-3, 11-4) exhibited different tumorigenic potentials when transplanted to athymic mice. HaCaT- and 1-6 cells were non-tumorigenic, 1-7 cells formed persisting epidermal cysts (benign tumours) and 11-3 and 11-4 cells developed into invasive squamous-cell carcinomas. TGF-beta1 inhibited thymidine uptake in a dose-dependent manner, a progressive decrease in response being associated with an increasing malignant potential (HaCaT > 1-6 > 1-7 = 11-4). HaCaT-cells and ras-clones expressed TGF-beta1 mRNA at similar levels, but cells of increasing malignant potential secreted markedly less receptor-binding TGF-beta (HaCaT > 1-6 = 1-7 > 11-3 > 11-4) into the culture medium. Whilst ras-transfected cells expressed fewer TGF-beta receptors than HaCaT cells, there was little difference between TGF-beta receptor number or affinity between the 4 transfected cell clones. The same was true for the TGF-beta receptor types, but Type-II receptors were expressed at lower levels by the malignant clones 11-3 and 11-4. When HaCaT and ras-transfected cells were investigated for their response to exogenous EGF, cells were refractory (1-7,11-4), partially stimulated (1-6) or fully stimulated (HaCaT). Cells with increasing malignant potential produced increasing amounts of endogenous TGF-alpha (11-4 = 11-3 > 1-7 = 1-6 > HaCaT). All tumorigenic ras clones expressed higher mRNA levels than HaCaT-cells. Ras-transfected clones expressed fewer high- and low-affinity EGF receptors than HaCaT cells with a tendency toward increased numbers of high-affinity EGF receptors associated with increasing malignant potential (11-4 = 11-3 > 1-7 > 1-6) but these changes were associated with a progressive decrease in receptor affinity. The results indicate that tumour progression in human epidermal keratinocytes transfected with c-Ha-ras is associated with a progressive abrogation of TGF-beta1 and EGF growth control. They suggest that the increased autonomous growth potential associated with advanced stages of epithelial tumour progression can be defined more closely using a cellular profile of TGF-beta and EGF.
引用
收藏
页码:461 / 470
页数:10
相关论文
共 27 条
  • [1] BOUKAMP P, 1990, CANCER RES, V50, P2840
  • [2] NORMAL KERATINIZATION IN A SPONTANEOUSLY IMMORTALIZED ANEUPLOID HUMAN KERATINOCYTE CELL-LINE
    BOUKAMP, P
    PETRUSSEVSKA, RT
    BREITKREUTZ, D
    HORNUNG, J
    MARKHAM, A
    FUSENIG, NE
    [J]. JOURNAL OF CELL BIOLOGY, 1988, 106 (03) : 761 - 771
  • [3] CARPENTER G, 1990, J BIOL CHEM, V265, P7709
  • [4] TRANSFORMATION OF MOUSE MAMMARY EPITHELIAL-CELLS WITH THE HA-RAS BUT NOT WITH THE NEU ONCOGENE RESULTS IN A GENE DOSAGE-DEPENDENT INCREASE IN TRANSFORMING GROWTH FACTOR-ALPHA PRODUCTION
    CIARDIELLO, F
    HYNES, N
    KIM, N
    VALVERIUS, EM
    LIPPMAN, ME
    SALOMON, DS
    [J]. FEBS LETTERS, 1989, 250 (02) : 474 - 478
  • [5] INVITRO TRANSFORMATION OF HUMAN SKIN EPITHELIAL-CELLS - ROLE OF RAS ONCOGENE IN MALIGNANT PROGRESSION
    FUSENIG, NE
    BOUKAMP, P
    BREITKREUTZ, D
    HULSEN, A
    PETRUSEVSKA, S
    CERUTTI, P
    STANBRIDGE, E
    [J]. TOXICOLOGY IN VITRO, 1990, 4 (4-5) : 627 - 634
  • [6] TUMOR PROGRESSION IN EXPERIMENTAL ORAL CARCINOGENESIS IS ASSOCIATED WITH CHANGES IN EGF AND TGF-BETA RECEPTOR EXPRESSION AND ALTERED RESPONSES TO THESE GROWTH-FACTORS
    GAME, SM
    STONE, A
    SCULLY, C
    PRIME, SS
    [J]. CARCINOGENESIS, 1990, 11 (06) : 965 - 973
  • [7] CHARACTERIZATION OF THE MOUSE TRANSFORMING GROWTH FACTOR-BETA-1 PROMOTER AND ACTIVATION BY THE HA-RAS ONCOGENE
    GEISER, AG
    KIM, SJ
    ROBERTS, AB
    SPORN, MB
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (01) : 84 - 92
  • [8] PREVALENCE OF ABERRANT EXPRESSION OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR IN HUMAN CANCERS
    GULLICK, WJ
    [J]. BRITISH MEDICAL BULLETIN, 1991, 47 (01) : 87 - 98
  • [9] HEBERT CD, 1989, CANCER RES, V49, P3196
  • [10] INHIBITION OF ENDOTHELIAL REGENERATION BY TYPE-BETA TRANSFORMING GROWTH-FACTOR FROM PLATELETS
    HEIMARK, RL
    TWARDZIK, DR
    SCHWARTZ, SM
    [J]. SCIENCE, 1986, 233 (4768) : 1078 - 1080